Clinical Trial Update: The Safety and Utility of Skin Testing With XOLAIR® (Omalizumab) and Placebo Omalizumab (Formulation Excipients) [Phase 4]

View source ↗

Summary

Phase 4 study evaluating skin testing with XOLAIR (omalizumab) and placebo excipients to assess safety and utility in healthy individuals and asthma patients; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Xolair (omalizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Healthy, Asthma | Phase 4 | Status: COMPLETED | Results posted: 2011-02-14